In contrast to previous opinions, it is now well established that neurogenesis occurs in the adult mammalian brain, at least in restricted areas where cells with stem cell like properties can be found. While great efforts have been expended to investigate the intrinsic properties of neural stem cells (NSCs) and the factors regulating their differentiation during the last decade, recent lines of research have begun to explore their therapeutic potential. This essay briefly summarizes the current state of stem cell research and gives a survey of the experimental approaches employed to investigate potential therapeutic applications of NSCs in the treatment of Parkinson disease and glioblastoma.
Table of Contents
1. Introduction
2. Neural stem cells in the adult central nervous system
2.1 History
2.2 Characteristics and characterization of neural stem cells
2.3 Localization of neural stem cells in the mammalian brain
2.4 Functions of neural stem cells in the adult brain
3. Neural stem cells in the treatment of glioma
3.1 Introduction
3.2 Anti-tumour activity of neural stem cells
3.3 Neural stem cells track down tumour cells
4. Conclusion
5. Engineering Neurons for Parkinson Disease
5.1 Introduction
5.2 Replacement therapies for Parkinson’s disease
5.3 Neural stem cells as donors for dopaminergic neurons
5.4 Conclusion
6. Summary
Objectives and Research Focus
This essay explores the therapeutic potential of neural stem cells (NSCs) in addressing severe central nervous system disorders, specifically focusing on the treatment of glioblastoma and Parkinson's disease. The work examines the biological properties of NSCs and evaluates current experimental strategies for cell-based therapies.
- Biological characterization and localization of adult neural stem cells.
- Mechanisms of NSC-mediated anti-tumour activity in glioblastoma.
- Tumour-targeted migratory behaviour of transplanted neural progenitor cells.
- Strategies for engineering dopaminergic neurons for Parkinson's disease treatment.
- Evaluation of clinical challenges and the potential for future therapeutic applications.
Excerpt from the Book
Neural stem cells in the adult central nervous system
It has long been thought that differentiation and regeneration in the central nervous system (CNS) would only be possible during development. “Once the development was ended, the fonts of growth and regeneration …. dried up irrevocably”, as Ramon y Cajal (1928) summarized the current opinion on this issue in the early 20th century. Cajal´s statement was based on the observation that there was no apparent mitotic activity in CNS, and that intermediate forms which could be considered to represent early forms of the high complex neurons seemed to be lacking. This view was challenged by the introduction of the 3H-thymidine autoradiographic method which allowed for the identification of dividing cells. By using this technique, Altman (1962) was the first to propose neurogenesis in the mammalian brain, and in a series of papers published during the 1960s he reported the existence of newly formed neurons in various brain regions , including the olfactory bulb, the hippocampus, and the neocortex (see Gross, 2000, for a review). The occurrence of neurogenesis in the adult CNS was subsequently established by the introduction of the thymidine analogue BrdU as another in vivo marker of proliferating cells which can be combined with immunostaining for cell-type specific markers (Lois and Alvarez-Buylla 1993) and by the establishment of a culture method for NSCs (Reynolds and Weiss 1992).
Summary of Chapters
1. Introduction: Provides an overview of the shift in scientific opinion regarding adult neurogenesis and outlines the scope of the essay concerning Parkinson's disease and glioblastoma.
2. Neural stem cells in the adult central nervous system: Reviews the historical development of the field and defines the core characteristics, localization, and functional roles of NSCs in the adult brain.
3. Neural stem cells in the treatment of glioma: Analyzes the therapeutic potential of NSCs to inhibit tumour growth and their capacity to selectively migrate toward tumour foci in the brain.
4. Conclusion: Summarizes the current research status on NSC applications in glioblastoma, acknowledging initial success in rodent models and the need for future exploration of migration mechanisms.
5. Engineering Neurons for Parkinson Disease: Discusses the rationale for cell replacement therapy in Parkinson's disease and explores experimental approaches to differentiate NSCs into functional dopaminergic neurons.
6. Summary: Recaps the progress in utilizing NSCs for CNS disorders and emphasizes the necessity of bridging preclinical findings with human clinical trials.
Keywords
Neural stem cells, Neurogenesis, Glioblastoma, Parkinson's disease, Dopaminergic neurons, Cell replacement therapy, Neurosphere, Tumour migration, Oncolytic activity, Regenerative medicine, Stem cell transplantation, Brain repair, Neurological disorders.
Frequently Asked Questions
What is the primary focus of this work?
The essay examines the biological properties of neural stem cells and their promising role as a therapeutic tool for treating severe central nervous system disorders, specifically focusing on glioblastoma and Parkinson's disease.
What are the central thematic areas discussed?
The document covers the history and definition of neural stem cells, their migratory capabilities in the context of brain tumours, and the experimental methods used to engineer them for replacing lost dopaminergic cells in patients.
What is the overarching research goal?
The essay aims to summarize the current state of stem cell research and provide a survey of experimental approaches that demonstrate the therapeutic potential of NSCs in medical treatments.
Which scientific methods are primarily highlighted?
The work discusses methodologies such as the neurosphere formation assay, genetic engineering for tumour inhibition (e.g., IL-4 secretion, cytosine deaminase transduction), and transcription factor-mediated cell differentiation (e.g., Nurr-1).
What is covered in the main body of the text?
The main body details the biological classification of NSCs, their role in tracking tumour cells, and the evolution of grafting techniques for Parkinson's disease from fetal tissue to engineered stem cells.
Which keywords best characterize this research?
Key terms include Neural stem cells, Neurogenesis, Glioblastoma, Parkinson's disease, Dopaminergic neurons, and cell replacement therapy.
How do NSCs contribute to the treatment of glioblastoma?
NSCs exhibit inherent oncolytic activity and a remarkable capacity to migrate selectively towards tumour foci, allowing them to deliver therapeutic genes or agents directly to the tumour site.
Why is Parkinson's disease considered a suitable candidate for cell replacement therapy?
The disease is restricted to a relatively confined area of the brain, and its pathophysiology—specifically the loss of dopaminergic neurons—is well understood, providing a clear target for restoring lost neurological function.
- Quote paper
- PhD Burkhard Niewoehner (Author), 2003, Neural Stem Cells and their Therapeutic Potenial, Munich, GRIN Verlag, https://www.grin.com/document/47832
